Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 7464320, 9 pages
https://doi.org/10.1155/2018/7464320
Research Article

Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes

1Department of Cardiology, Mater Dei Hospital and University of Malta, Msida, Malta
2Department of Cardiology, Mater Dei Hospital, Msida, Malta
3Mater Dei Hospital, Msida, Malta
4Statistics & Operations Research, Faculty of Science, University of Malta, Msida, Malta
5Mater Dei Hospital and University of Malta, Msida, Malta

Correspondence should be addressed to Stephen Fava; tm.ude.mu@avaf.nehpets

Received 2 January 2018; Revised 1 June 2018; Accepted 24 June 2018; Published 22 July 2018

Academic Editor: Andrea Flex

Copyright © 2018 Caroline Jane Magri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Emerging Risk Factors Collaboration, N. Sarwar, P. Gao et al., “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies,” The Lancet, vol. 375, no. 9733, pp. 2215–2222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. ADVANCE Collaborative Group, A. Patel, S. MacMahon et al., “Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2560–2572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Östgren, J. Sundström, B. Svennblad, L. Lohm, P. M. Nilsson, and G. Johansson, “Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with type 2 diabetes: a cohort study in primary care,” Diabetic Medicine, vol. 30, no. 5, pp. e170–e177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Goto, O. A. Arah, M. Goto, Y. Terauchi, and M. Noda, “Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis,” BMJ, vol. 347, article f4533, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Fava, O. Aquilina, J. Azzopardi, H. A. Muscat, and F. F. Fenech, “The prognostic value of blood glucose in diabetic patients with acute myocardial infarction,” Diabetic Medicine, vol. 13, no. 1, pp. 80–83, 1996. View at Publisher · View at Google Scholar
  7. A.-M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg, “Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events,” European Heart Journal, vol. 26, no. 13, pp. 1255–1261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Tu, S. M. Twigg, and C. Semsarian, “Sudden death in type 1 diabetes: the mystery of the “dead in bed” syndrome,” International Journal of Cardiology, vol. 138, no. 1, pp. 91–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Reno, D. Daphna-Iken, Y. S. Chen, J. VanderWeele, K. Jethi, and S. J. Fisher, “Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation,” Diabetes, vol. 62, no. 10, pp. 3570–3581, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Desouza, H. Salazar, B. Cheong, J. Murgo, and V. Fonseca, “Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring,” Diabetes Care, vol. 26, no. 5, pp. 1485–1489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Sreenan, M. Andersen, B. L. Thorsted, M. L. Wolden, and M. Evans, “Increased risk of severe hypoglycemic events with increasing frequency of non-severe hypoglycemic events in patients with type 1 and type 2 diabetes,” Diabetes Therapy, vol. 5, no. 2, pp. 447–458, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Yasunari, T. Mita, Y. Osonoi et al., “Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery,” Endocrinology, vol. 155, no. 6, pp. 2244–2253, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. W. L. Jin, K. Azuma, T. Mita et al., “Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta,” Diabetologia, vol. 54, no. 7, pp. 1921–1929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Giménez, R. Gilabert, J. Monteagudo et al., “Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes,” Diabetes Care, vol. 34, no. 1, pp. 198–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. G. Timmons, S. G. Cunningham, C. A. R. Sainsbury, and G. C. Jones, “Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes,” Journal of Diabetes and its Complications, vol. 31, no. 2, pp. 479–482, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Wu, H. Shen, H. Liu, Y. Wang, Y. Bai, and P. Han, “Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo,” Cardiovascular Diabetology, vol. 15, no. 1, p. 109, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. M. F. Piepoli, A. W. Hoes, S. Agewall et al., “2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR),” Giornale Italiano Di Cardiologia, vol. 18, no. 7, pp. 547–612, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. E. R. Fährmann, L. Adkins, C. J. Loader et al., “Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study,” Diabetes Research and Clinical Practice, vol. 107, no. 2, pp. 280–289, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Engelen, I. Ferreira, C. D. Stehouwer, P. Boutouyrie, S. Laurent, and Reference Values for Arterial Measurements Collaboration, “Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors,” European Heart Journal, vol. 34, no. 30, pp. 2368–2380, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. W. Neil, “10-year follow-up of intensive glucose control in type 2 diabetes,” The New England Journal of Medicine, vol. 359, no. 15, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. E. Bonds, M. E. Miller, R. M. Bergenstal et al., “The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study,” BMJ, vol. 340, article b4909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. O. J. Phung, E. Schwartzman, R. W. Allen, S. S. Engel, and S. N. Rajpathak, “Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis,” Diabetic Medicine, vol. 30, no. 10, pp. 1160–1171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. L. Morgan, J. Mukherjee, S. Jenkins-Jones, S. E. Holden, and C. J. Currie, “Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality,” Diabetes, Obesity & Metabolism, vol. 16, no. 10, pp. 977–983, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Holden, S. Jenkins-Jones, C. L. Morgan, G. Schernthaner, and C. J. Currie, “Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer,” Diabetes, Obesity and Metabolism, vol. 17, no. 4, pp. 350–362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Wang, A. Alexanian, R. Ying et al., “Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 712–720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. N. G. Joy, D. B. Tate, L. M. Younk, and S. N. Davis, “Effects of acute and antecedent hypoglycemia on endothelial function and markers of atherothrombotic balance in healthy humans,” Diabetes, vol. 64, no. 7, pp. 2571–2580, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Razavi Nematollahi, A. E. Kitabchi, F. B. Stentz et al., “Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects,” Metabolism, vol. 58, no. 4, pp. 443–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Kiec-Wilk, B. Matejko, U. Razny et al., “Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus,” Atherosclerosis, vol. 251, pp. 334–338, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. G. P. Fadini, M. Albiero, S. Vigili de Kreutzenberg, and A. Avogaro, “Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients,” Journal of Endocrinological Investigation, vol. 38, no. 7, pp. 733–738, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. S. Peña, J. J. Couper, J. Harrington et al., “Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes,” Diabetes Technology & Therapeutics, vol. 14, no. 6, pp. 457–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Zoungas, M. Woodward, Q. Li et al., “Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes,” Diabetologia, vol. 57, no. 12, pp. 2465–2474, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Edge, T. James, and B. Shine, “Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years,” Diabetic Medicine, vol. 27, no. 11, pp. 1284–1288, 2010. View at Publisher · View at Google Scholar · View at Scopus